M
Meghan Laszlo
2
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Sep 24, 2026
EP 56: GLP-1s and Neuroendocrine Cancer: What Do We Know?
19:57
20:03
20:21
20:29

Jessica ThomasHOST
She says she's seeing more patients remain on GLP-1 medications After a cancer diagnosis.

Meghan LaszloGUEST
Initially, when I was seeing patients come in on a DLP one that then had a cancer diagnosis after starting it, most of them are taken off the DLP one right away.

Meghan LaszloGUEST
But what I've seen now is that a lot of folks are staying on them, that there might actually be secondary benefits to being on them during treatment.

Meghan LaszloGUEST
But there's a lot of variation in the dose that somebody's on and how much it's affecting their body and their eating habits.
EP 56: GLP-1s and Neuroendocrine Cancer: What Do We Know?
19:57
20:03
20:21
20:29

Jessica ThomasHOST
She says she's seeing more patients remain on GLP-1 medications After a cancer diagnosis.

Meghan LaszloGUEST
Initially, when I was seeing patients come in on a DLP one that then had a cancer diagnosis after starting it, most of them are taken off the DLP one right away.

Meghan LaszloGUEST
But what I've seen now is that a lot of folks are staying on them, that there might actually be secondary benefits to being on them during treatment.

Meghan LaszloGUEST
But there's a lot of variation in the dose that somebody's on and how much it's affecting their body and their eating habits.